Many studies have demonstrated that people with schizophrenia who take second-generation antipsychotic drugs like olanzapine and risperidone frequently develop symptoms like diabetes and obesity, which may be because that the second-generation antipsychotics might increase the production of ghrelin [103]. The gene discussed is GHRL; the disease is diabetes mellitus.